This topic contains a solution. Click here to go to the answer

Author Question: In a ____ study, the drug or treatment is given to large groups of people to confirm its ... (Read 41 times)

asan beg

  • Hero Member
  • *****
  • Posts: 570
In a ____ study, the drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
 
  a. pilot
 b. Phase I
 c. Phase II
 d. Phase III

Question 2

Rich performed a two-tailed test for an experiment in which n=15 . He could not find his t critical values table but he remembered the tcv at df = 20 . He decided to compare his tobt to this tcv. Is he more likely to make a Type I or a Type II error in this situation?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

allisonblackmore

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

d

Answer to Question 2

Rich is more likely to make a Type I error in this case. He will use a tcv that is smaller than the one he should be using and thus he might call the result significant when it is not (a false alarm).





 

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library